Trial intelligence / Profile preview

Hemostatic changes after COVID-19 vaccination in patients with hematologic malignancy diseases

TCTR20211109005Terminated

Sponsor
Siriraj Hospital
Start
Jul 2021
Countries
1
01

Overview

Trial in hematopoietic malignancies, sponsored by Siriraj Hospital. Started Jul 2021; status: terminated.

02

Conditions

hematopoietic malignancies

Beyond the preview

Go deeper on TCTR20211109005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20211109005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call